Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 154 articles: HTML format Text format

Single Articles

February 2010
1. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
   Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
   J Med Virol. 2010;82:575-582.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. MEFFRE C , Le Strat Y, Delarocque-Astagneau E, Dubois F, et al
   Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors.
   J Med Virol. 2010;82:546-555.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LEE S , Watson MW, Flexman JP, Cheng W, et al
   Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alphaand ribavirin therapy.
   J Med Virol. 2010;82:568-574.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. SONG YJ , Jeong HJ, Kim YJ, Lee SW, et al
   Analysis of complete genome sequences of swine hepatitis E virus and possible risk factors for transmission of HEV to humans in Korea.
   J Med Virol. 2010;82:583-591.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. CANTALOUBE JF , Gallian P, Bokilo A, Jordier F, et al
   Analysis of hepatitis C virus strains circulating in Republic of the Congo.
   J Med Virol. 2010;82:562-567.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
   Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.
   J Med Virol. 2010;82:539-545.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SHIOGAMA K , Teramoto H, Morita Y, Mizutani Y, et al
   Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 years.
   J Med Virol. 2010;82:556-561.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. ANTONELLI A , Ferri C, Ferrari SM, Ghiri E, et al
   High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia.
   J Med Virol. 2010;82:297-303.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
9. CHEN DQ , Zeng Y, Zhou J, Yang L, et al
   Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population.
   J Med Virol. 2010;82:371-378.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. POURKARIM MR , Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, et al
    Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations.
    J Med Virol. 2010;82:379-389.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
    Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
    J Med Virol. 2010;82:390-395.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. BLOQUEL B , Jeulin H, Burty C, Letranchant L, et al
    Occult hepatitis B infection in patients infected with HIV: Report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.
    J Med Virol. 2009;82:206-212.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. TAKAHASHI M , Tamura K, Hoshino Y, Nagashima S, et al
    A nationwide survey of hepatitis E virus infection in the general population of Japan.
    J Med Virol. 2009;82:271-281.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. AGDAMAG DM , Kageyama S, Leano PS, Solante RM, et al
    Prediction of response to treatment of chronic hepatitis B with pegylated interferon in the Philippines.
    J Med Virol. 2009;82:213-219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. ALMROTH G , Ekermo B, Akerlind B, Mansson AS, et al
    Monitoring hepatitis C infection in a major Swedish nephrology unit and molecular resolution of a new case of nosocomial transmission.
    J Med Virol. 2009;82:249-256.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. AKKARATHAMRONGSIN S , Praianantathavorn K, Hacharoen N, Theamboonlers A, et al
    Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand.
    J Med Virol. 2009;82:257-262.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. DEMETRIOU VL , van de Vijver DA, Hezka J, Kostrikis LG, et al
    Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    J Med Virol. 2009;82:263-270.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ZHU Z , Wilson AT, Gopalakrishna K, Brown KE, et al
    Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.
    J Med Virol. 2009;82:239-248.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. TONIUTTO P , Fattovich G, Fabris C, Minisini R, et al
    Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B.
    J Med Virol. 2009;82:224-331.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. VIAZOV S , Ross SS, Kyuregyan KK, Timm J, et al
    Hepatitis C virus recombinants are rare even among intravenous drug users.
    J Med Virol. 2009;82:232-238.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. HAYAJNEH WA , Masaadeh HA, Hayajneh YA
    A case-control study of risk factors for hepatitis B virus infection in North Jordan.
    J Med Virol. 2009;82:220-223.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
22. KANAI Y , Tsujikawa M, Yunoki M, Nishiyama S, et al
    Long-term shedding of hepatitis E virus in the feces of pigs infected naturally, born to sows with and without maternal antibodies.
    J Med Virol. 2009;82:69-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. LEE YM , Lin HJ, Chen YJ, Lee CM, et al
    Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w.
    J Med Virol. 2009;82:57-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. FALASCA K , Ucciferri C, Mancino P, Gorgoretti V, et al
    Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response.
    J Med Virol. 2009;82:49-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ZHAO C , Zhang W, Tian X, Fang C, et al
    Proteomic analysis of cell lines expressing small hepatitis B surface antigen revealed decreased glucose-regulated protein 78 kDa expression in association with higher susceptibility to apoptosis.
    J Med Virol. 2009;82:14-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. HUANG X , Qin Y, Zhang P, Tang G, et al
    PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.
    J Med Virol. 2009;82:23-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. KOBAYASHI M , Akuta N, Suzuki F, Hosaka T, et al
    Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2009;82:41-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
28. BOUZGARROU N , Hassen E, Mahfoudh W, Gabbouj S, et al
    NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/Ribavirin therapy.
    J Med Virol. 2009;81:2021-2028.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. WANG C , Heim A, Schlaphoff V, Suneetha PV, et al
    Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
    J Med Virol. 2009;81:2079-2088.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. STROFFOLINI T , Almasio PL, Sagnelli E, Mele A, et al
    Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study.
    J Med Virol. 2009;81:1999-2006.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. ZAMPINO R , Marrone A, Merola A, Trani B, et al
    Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth.
    J Med Virol. 2009;81:2012-2020.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. LEGRAND-ABRAVANEL F , Colson P, Leguillou-Guillemette H, Alric L, et al
    Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
    J Med Virol. 2009;81:2029-2035.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. KABA M , Davoust B, Marie JL, Barthet M, et al
    Frequent transmission of hepatitis E virus among piglets in farms in Southern France.
    J Med Virol. 2009;81:1750-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. VAN DAMME P , von Sonnenburg F, Hatz C, Hoet B, et al
    Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.
    J Med Virol. 2009;81:1710-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. WU KT , Chung KM, Feng IC, Sheu MJ, et al
    Acute hepatitis E virus infection in Taiwan 2002-2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses.
    J Med Virol. 2009;81:1734-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. COTE PJ , Butler SD, George AL, Fairman J, et al
    Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.
    J Med Virol. 2009;81:1760-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. CHOI CS , Cho EY, Park R, Kim SJ, et al
    X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma.
    J Med Virol. 2009;81:1721-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. FOGEDA M , Avellon A, Cilla CG, Echevarria JM, et al
    Imported and autochthonous hepatitis E virus strains in Spain.
    J Med Virol. 2009;81:1743-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. NDONGO N , Rechoum Y, De Sequeira S, Zoulim F, et al
    Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.
    J Med Virol. 2009;81:1726-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ERHARDT A , Gobel T, Ludwig A, Lau GK, et al
    Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
    J Med Virol. 2009;81:1716-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
41. TORRE F , Basso M, Giannini EG, Feasi M, et al
    Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: Clinical considerations and disease burden.
    J Med Virol. 2009;81:1882-1886.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DI LELLO FA , Pineiro Y Leone FG, Munoz G, Campos RH, et al
    Diversity of hepatitis B and C viruses in Chile.
    J Med Virol. 2009;81:1887-1894.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
43. HUANG Q , Wang L, Bai S, Lin W, et al
    Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2.
    J Med Virol. 2009;81:1539-1550.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. JI F , Zhou L, Ma S, Li F, et al
    Dynamic changes of HBV quasispecies and deletion patterns in a chronic hepatitis B patient.
    J Med Virol. 2009;81:1551-1559.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. DONG Y , Liu SL, Zhai XJ, Zhu FC, et al
    A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    J Med Virol. 2009;81:1517-1524.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. LIN L , Libbrecht L, Verbeeck J, Verslype C, et al
    Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: Methods and clinical relevance.
    J Med Virol. 2009;81:1569-1575.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. CHENG JC , Yeh YJ, Pai LM, Chang ML, et al
    293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    J Med Virol. 2009;81:1560-1568.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. MAKHZANGY HE , Esmat G, Said M, Elraziky M, et al
    Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.
    J Med Virol. 2009;81:1576-1583.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. KIYOHARA T , Ouchi Y, Hasegawa Y, Sato T, et al
    An in-house-anti-hepatitis A virus (HAV)-specific immunoglobulin M capture enzyme-linked immunosorbent assay: Evaluation and application to an HAV outbreak.
    J Med Virol. 2009;81:1513-1516.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. JANG JS , Kim HS, Kim HJ, Shin WG, et al
    Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    J Med Virol. 2009;81:1531-1538.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. VIANA R , Wang R, Yu MC, Welschinger R, et al
    Hepatitis B viral loads in southern African Blacks with hepatocellular carcinoma.
    J Med Virol. 2009;81:1525-1530.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. LI W , Sun Q, She R, Wang D, et al
    Experimental infection of mongolian gerbils by a genotype 4 strain of swine hepatitis E virus.
    J Med Virol. 2009;81:1591-1596.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
    Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C.
    J Med Virol. 2009;81:1584-1590.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
54. TODA T , Mitsui T, Tsukamoto Y, Ebara T, et al
    Molecular analysis of transmission of hepatitis C virus in a nurse who acquired acute hepatitis C after caring for a viremic patient with epistaxis.
    J Med Virol. 2009;81:1363-1370.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ZHAO C , Ma Z, Harrison TJ, Feng R, et al
    A novel genotype of hepatitis E virus prevalent among farmed rabbits in China.
    J Med Virol. 2009;81:1371-1379.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. ALZAHRANI AJ , Cruz DM, Obeid OE, Bukhari HA, et al
    Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia.
    J Med Virol. 2009;81:1343-1347.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. TOYODA H , Kumada T, Kiriyama S, Sone Y, et al
    Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    J Med Virol. 2009;81:1354-1362.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. BORGNIET O , Parvaz P, Bouix C, Chevallier P, et al
    Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    J Med Virol. 2009;81:1336-1342.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. CAVLEK TV , Margan IG, Lepej SZ, Kolaric B, et al
    Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
    J Med Virol. 2009;81:1348-1353.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
60. MOTA A , Guedes F, Areias J, Pinho L, et al
    Epidemiological study of genotypes of hepatitis B virus in northern Portugal.
    J Med Virol. 2009;81:1170-1176.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. IACOMI F , Vincenti D, Vairo F, Solmone M, et al
    Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    J Med Virol. 2009;81:1151-1156.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. VAN HOUDT R , van den Berg CH, Stolte IG, Bruisten SM, et al
    Two decades of hepatitis B infections among drug users in Amsterdam: Are they still a high-risk group?
    J Med Virol. 2009;81:1163-1169.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. ASKAR E , Bregadze R, Mertens J, Schweyer S, et al
    TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    J Med Virol. 2009;81:1204-1211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. KHAN A , Tanaka Y, Azam Z, Abbas Z, et al
    Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
    J Med Virol. 2009;81:1189-1197.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. NIU Y , Komatsu N, Komohara Y, Matsueda S, et al
    A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
    J Med Virol. 2009;81:1232-1240.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. KAGEYAMA S , Agdamag DM, Alesna ET, Abellanosa-Tac-An IP, et al
    Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.
    J Med Virol. 2009;81:1157-1162.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. QUARANTINI LC , Miranda-Scippa A, Batista-Neves S, Powell VB, et al
    A neuropsychological study comparing patients infected with HCV and HBV without psychiatric comorbidities.
    J Med Virol. 2009;81:1184-1188.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. ARAUJO FM , Machado-Lima A, Durham AM, Teixeira R, et al
    Sequence and structural analysis of the 5' noncoding region of hepatitis C virus in patients with chronic infection.
    J Med Virol. 2009;81:1212-1219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. GUO Y , Li Y, Mu S, Zhang J, et al
    Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
    J Med Virol. 2009;81:1177-1183.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. MAIA LP , Martins-Filho OA, Teixeira-Carvalho A, Speziali E, et al
    Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
    J Med Virol. 2009;81:1220-1231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. CASTILLO I , Bartolome J, Quiroga JA, Barril G, et al
    Hepatitis C virus infection in the family setting of patients with occult hepatitis C.
    J Med Virol. 2009;81:1198-1203.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
72. CAVINTA L , Sun J, May A, Yin J, et al
    A new isolate of hepatitis B virus from the Philippines possibly representing a new subgenotype C6.
    J Med Virol. 2009;81:983-987.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. IBRAHIM AS , Alkhal A, Jacob J, Ghadban W, et al
    Hepatitis E in Qatar imported by expatriate workers from Nepal: Epidemiological characteristics and clinical manifestations.
    J Med Virol. 2009;81:1047-1051.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    J Med Virol. 2009;81:1032-1039.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. KIM JK , Chang HY, Lee JM, Baatarkhuu O, et al
    Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    J Med Virol. 2009;81:1002-1008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. PIZZILLO P , Almasio PL, Ferraro D, Craxi A, et al
    HCV genotypes in Sicily: Is there any evidence of a shift?
    J Med Virol. 2009;81:1040-1046.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. TAI AL , Cheng PK, Ip SM, Wong RM, et al
    Molecular epidemiology of hepatitis E virus in Hong Kong.
    J Med Virol. 2009;81:1062-1068.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. ELKADY A , Tanaka Y, Kurbanov F, Sugauchi F, et al
    Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication.
    J Med Virol. 2009;81:1015-1023.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. TAKKENBERG RB , Zaaijer HL, Molenkamp R, Menting S, et al
    Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients.
    J Med Virol. 2009;81:988-995.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. ENDO T , Fujimoto K, Nishio M, Yamamoto S, et al
    Case report: Clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
    J Med Virol. 2009;81:979-982.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. TAMORI A , Hayashi T, Shinzaki M, Kobayashi S, et al
    Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    J Med Virol. 2009;81:1009-1014.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. MA H , Song X, Li Z, Harrison TJ, et al
    Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
    J Med Virol. 2009;81:1052-1061.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. CHU FY , Chiang SC, Su FH, Chang YY, et al
    Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    J Med Virol. 2009;81:973-978.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SHEBL FM , El-Kamary SS, Saleh DA, Abdel-Hamid M, et al
    Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.
    J Med Virol. 2009;81:1024-1031.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. SELABE SG , Song E, Burnett RJ, Mphahlele MJ, et al
    Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    J Med Virol. 2009;81:996-1001.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
86. INDOLFI G , Resti M
    Perinatal transmission of hepatitis C virus infection.
    J Med Virol. 2009;81:836-843.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. QIN Y , Zhang J, Mao R, Guo H, et al
    Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers.
    J Med Virol. 2009;81:807-814.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. OHKAWA K , Takehara T, Kato M, Kanada A, et al
    Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.
    J Med Virol. 2009;81:798-806.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. RYU SH , Fan X, Xu Y, Elbaz T, et al
    Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt.
    J Med Virol. 2009;81:844-847.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. KATSOULIDOU A , Paraskevis D, Magiorkinis E, Moschidis Z, et al
    Molecular characterization of occult hepatitis B cases in Greek blood donors.
    J Med Virol. 2009;81:815-825.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. KOSKINAS J , Zacharakis G, Sidiropoulos J, Elefsiniotis J, et al
    Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: A preliminary report on treatment, safety and efficacy.
    J Med Virol. 2009;81:848-852.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. FANG Y , Teng X, Xu WZ, Li D, et al
    Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C.
    J Med Virol. 2009;81:826-835.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. VELDHUIJZEN IK , Mes TH, Mostert MC, Niesters HG, et al
    An improved approach to identify epidemiological and phylogenetic transmission pairs of source and contact tracing of hepatitis B.
    J Med Virol. 2009;81:425-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. HUBSCHEN JM , Mugabo J, Peltier CA, Karasi JC, et al
    Exceptional genetic variability of hepatitis B virus indicates that Rwanda is east of an emerging African genotype E/A1 divide.
    J Med Virol. 2009;81:435-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. HAYASHI K , Katano Y, Honda T, Ishigami M, et al
    Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.
    J Med Virol. 2009;81:459-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. CHANG ML , Chen TH, Chang MY, Yeh CT, et al
    Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression.
    J Med Virol. 2009;81:467-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. CHA CK , Kwon HC, Cheong JY, Cho SW, et al
    Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    J Med Virol. 2009;81:417-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. ZAAIJER HL , Takkenberg RB, Weegink CJ, Rebers SP, et al
    Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
    J Med Virol. 2009;81:413-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.
    J Med Virol. 2009;81:452-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. CARPENTIER A , Conti F, Carriere M, Aoudjehane L, et al
     Analysis of gene transcription in sera during chronic hepatitis C infection.
     J Med Virol. 2009;81:473-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
     Long-term follow-up of patients with hepatitis C with a normal alanine aminotransferase.
     J Med Virol. 2009;81:446-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. COHEN STUART JW , Velema M, Schuurman R, Boucher CA, et al
     Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
     J Med Virol. 2009;81:441-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. LUKHWARENI A , Burnett RJ, Selabe SG, Mzileni MO, et al
     Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
     J Med Virol. 2009;81:406-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
104. CHOI JW , Ahn SH, Park JY, Chang HY, et al
     Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
     J Med Virol. 2009;81:594-601.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. HUANG YW , Hu CY, Chen CL, Liao YT, et al
     Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.
     J Med Virol. 2009;81:588-593.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. MORI N , Imamura M, Kawakami Y, Saneto H, et al
     Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy.
     J Med Virol. 2009;81:640-649.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. FERREIRA RC , Rodrigues FP, Teles SA, Lopes CL, et al
     Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users.
     J Med Virol. 2009;81:602-609.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. CUEVAS JM , Torres-Puente M, Jimenez-Hernandez N, Bracho MA, et al
     Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus.
     J Med Virol. 2009;81:650-656.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. INOKUCHI M , Ito T, Uchikoshi M, Shimozuma Y, et al
     Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
     J Med Virol. 2009;81:619-627.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. LI CS , Chan PK, Tang JW
     Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong.
     J Med Virol. 2009;81:628-633.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. SIRIPANYAPHINYO U , Laohasinnarong D, Siripanee J, Kaeoket K, et al
     Full-length sequence of genotype 3 hepatitis E virus derived from a pig in Thailand.
     J Med Virol. 2009;81:657-664.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. SEME K , Vrhovac M, Mocilnik T, Maticic M, et al
     Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007.
     J Med Virol. 2009;81:634-639.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. VERDICHIO-MORAES CF , Toralles-Pereira C, Grotto RM, Silva GF, et al
     Allelic frequencies of HPA-1 to 5 human platelet antigens in patients infected with hepatitis C virus.
     J Med Virol. 2009;81:757-759.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. CHEHADEH W , Al-Nakib W
     Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
     J Med Virol. 2009;81:610-618.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. KYRKA A , Tragiannidis A, Cassimos D, Pantelaki K, et al
     Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
     J Med Virol. 2009;81:582-587.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
116. ZARIFE MA , Reis EA, Carmo TM, Lopes GB, et al
     Increased frequency of CD56(Bright) NK-cells, CD3(-)CD16(+)CD56(-) NK-cells and activated CD4(+)T-cells or B-cells in parallel with CD4(+)CDC25(High) T-cells control potentially viremia in blood donors with HCV.
     J Med Virol. 2009;81:49-59.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. SUZUKI F , Miyakoshi H, Kobayashi M, Kumada H, et al
     Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
     J Med Virol. 2009;81:27-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. ALEXOPOULOU A , Baltayiannis G, Eroglu C, Nastos T, et al
     Core mutations in patients with acute episodes of chronic HBV infection are associated with the emergence of new immune recognition sites and the development of high IgM anti-HBc index values.
     J Med Virol. 2009;81:34-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
119. DEMETRIOU VL , van de Vijver DA, Kostrikis LG
     Molecular epidemiology of hepatitis C infection in cyprus: Evidence of polyphyletic infection.
     J Med Virol. 2008;81:238-248.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. LIMQUIACO JL , Wong J, Wong VW, Wong GL, et al
     Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study.
     J Med Virol. 2008;81:224-229.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. CAROTENUTO P , Artsen A, Niesters HG, Osterhaus AD, et al
     In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
     J Med Virol. 2008;81:332-339.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. ROSS RS , Viazov S, Khudyakov YE, Xia GL, et al
     Transmission of hepatitis C virus in an orthopedic hospital ward.
     J Med Virol. 2008;81:249-257.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. MA ZM , Lin X, Wang YX, Tian XC, et al
     A double-spliced defective hepatitis B virus genome derived from hepatocellular carcinoma tissue enhanced replication of full-length virus.
     J Med Virol. 2008;81:230-237.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. MOHEBBI SR , Zali N, Derakhshan F, Tahami A, et al
     Molecular epidemiology of hepatitis delta virus (HDV) in Iran: A preliminary report.
     J Med Virol. 2008;80:2092-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. SHARKAWI FZ , Chudy M, Hanschmann KM, Kress J, et al
     Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays.
     J Med Virol. 2008;80:2086-91.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. NJOUOM R , Sartre MT, Timba I, Nerrienet E, et al
     Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C.
     J Med Virol. 2008;80:2079-85.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. MIYAGAWA M , Minami M, Fujii K, Sendo R, et al
     Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
     J Med Virol. 2008;80:2069-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. TABUCHI A , Tanaka J, Katayama K, Mizui M, et al
     Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: Transmission experiments to chimeric mice with human liver repopulated hepatocytes.
     J Med Virol. 2008;80:2064-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
129. MEIER V , Mihm S, Ramadori G
     Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
     J Med Virol. 2008;80:1912-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
130. DETERDING K , Constantinescu I, Nedelcu FD, Gervain J, et al
     Prevalence of HBV genotypes in Central and Eastern Europe.
     J Med Virol. 2008;80:1707-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
131. WOO HY , Choi JY, Jang JW, You CR, et al
     Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
     J Med Virol. 2008;80:1891-1899.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. FALASCA K , Ucciferri C, Mancino P, Vitacolonna E, et al
     Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection.
     J Med Virol. 2008;80:1900-1906.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. INDOLFI G , Bartolini E, Azzari C, Becciolini L, et al
     Intrafamilial transmission of hepatitis C virus: Infection of the father predicts the risk of perinatal transmission.
     J Med Virol. 2008;80:1907-1911.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. LI Y , Wang X, Chen F, Ma R, et al
     Clinical significance of a set of single nucleotide polymorphisms of hepatitis B virus core gene in Chinese Han patients with chronic hepatitis B.
     J Med Virol. 2008;80:1885-1890.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. KOBAYASHI M , Ikeda K, Arase Y, Suzuki F, et al
     Change of hepatitis B virus genotypes in acute and chronic infections in Japan.
     J Med Virol. 2008;80:1880-1884.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. MOENKEMEYER M , Schmidt RE, Wedemeyer H, Tillmann HL, et al
     GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients.
     J Med Virol. 2008;80:1933-1940.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. HEKMAT S , Mohraz M, Vahabpour R, Jam S, et al
     Frequency and genotype of GB virus C among Iranian patients infected with HIV.
     J Med Virol. 2008;80:1941-1946.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. MENDY M , D'Mello F, Kanellos T, Oliver S, et al
     Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections.
     J Med Virol. 2008;80:1537-46.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
139. CANTALOUBE JF , Gallian P, Laperche S, Elghouzzi MH, et al
     Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors.
     J Med Virol. 2008;80:1732-1739.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. FERRARO D , Genovese D, Argentini C, Giordano V, et al
     Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: The Camporeale model.
     J Med Virol. 2008;80:1723-1731.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. XIA X , Zhao W, Tee KK, Feng Y, et al
     Complete genome sequencing and phylogenetic analysis of HCV isolates from China reveals a new subtype, designated 6u.
     J Med Virol. 2008;80:1740-1746.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. OH HB , Kim SO, Cha CH, Hong SP, et al
     Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
     J Med Virol. 2008;80:1712-1719.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. AHMED RE , Karsany MS, Adam I
     Brief Report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women.
     J Med Virol. 2008;80:1747-1748.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. LIN A , Thadareddy A, Goldstein MJ, Lake-Bakaar G, et al
     Immune suppression leading to hepatitis C virus re-emergence after sustained virological response.
     J Med Virol. 2008;80:1720-1722.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
145. BARTOLOME J , Rodriguez-Inigo E, Quadros P, Vidal S, et al
     Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection.
     J Med Virol. 2008;80:1588-1594.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. YUN H , Kim D, Kim S, Kang S, et al
     High prevalence of HBV and HCV infection among intravenous drug users in Korea.
     J Med Virol. 2008;80:1570-1575.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. GIBNEY KB , Torresi J, Lemoh C, Biggs BA, et al
     Isolated core antibody hepatitis B in sub-Saharan African immigrants.
     J Med Virol. 2008;80:1565-1569.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. NICOT F , Legrand-Abravanel F, Lafont T, Dubois M, et al
     Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.
     J Med Virol. 2008;80:1523-1529.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. RODRIGUEZ-TORRES M , Rios-Bedoya CF, Ortiz-Lasanta G, Purcell-Arevalo D, et al
     Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks.
     J Med Virol. 2008;80:1576-1580.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. SAGNELLI E , Imparato M, Coppola N, Pisapia R, et al
     Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: A multicenter study.
     J Med Virol. 2008;80:1547-1553.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. PARBOOSING R , Paruk I, Lalloo UG
     Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality.
     J Med Virol. 2008;80:1530-1536.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. LAOI BN , Crowley B
     Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital.
     J Med Virol. 2008;80:1554-1564.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. NDONG-ATOME GR , Makuwa M, Ouwe-Missi-Oukem-Boyer O, Pybus OG, et al
     High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural gabon.
     J Med Virol. 2008;80:1581-1587.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
     Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
     J Med Virol. 2008;80:1302-7.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: